257 related articles for article (PubMed ID: 32925947)
1. TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
Mullen DJ; Yan C; Kang DS; Zhou B; Borok Z; Marconett CN; Farnham PJ; Offringa IA; Rhie SK
PLoS Genet; 2020 Sep; 16(9):e1009023. PubMed ID: 32925947
[TBL] [Abstract][Full Text] [Related]
2. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.
Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y
Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209
[TBL] [Abstract][Full Text] [Related]
3. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
4. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas.
Milewski D; Balli D; Ustiyan V; Le T; Dienemann H; Warth A; Breuhahn K; Whitsett JA; Kalinichenko VV; Kalin TV
PLoS Genet; 2017 Dec; 13(12):e1007097. PubMed ID: 29267283
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
7. Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells.
Lee Y; Wu Z; Yang S; Schreiner SM; Gonzalez-Smith LD; Rhie SK
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291764
[TBL] [Abstract][Full Text] [Related]
8. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas.
Chen PM; Wu TC; Shieh SH; Wu YH; Li MC; Sheu GT; Cheng YW; Chen CY; Lee H
Mol Cancer Res; 2013 Mar; 11(3):261-71. PubMed ID: 23271813
[TBL] [Abstract][Full Text] [Related]
9. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
[TBL] [Abstract][Full Text] [Related]
10. An Integrative Analysis of Transcriptome and Epigenome Features of ASCL1-Positive Lung Adenocarcinomas.
Miyashita N; Horie M; Suzuki HI; Yoshihara M; Djureinovic D; Persson J; Brunnström H; Lindskog C; Elfving H; Micke P; Saito A; Nagase T
J Thorac Oncol; 2018 Nov; 13(11):1676-1691. PubMed ID: 30121393
[TBL] [Abstract][Full Text] [Related]
11. Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.
Murugesan SN; Yadav BS; Maurya PK; Chaudhary A; Singh S; Mani A
J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180040
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH.
Xiong YC; Wang J; Cheng Y; Zhang XY; Ye XQ
Mol Cell Biochem; 2020 May; 468(1-2):185-193. PubMed ID: 32200471
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL.
Wei P; Zhang N; Wang Y; Li D; Wang L; Sun X; Shen C; Yang Y; Zhou X; Du X
Int J Biol Sci; 2015; 11(2):186-98. PubMed ID: 25561901
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic reprogramming of a distal developmental enhancer cluster drives SOX2 overexpression in breast and lung adenocarcinoma.
Abatti LE; Lado-Fernández P; Huynh L; Collado M; Hoffman MM; Mitchell JA
Nucleic Acids Res; 2023 Oct; 51(19):10109-10131. PubMed ID: 37738673
[TBL] [Abstract][Full Text] [Related]
15. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
[TBL] [Abstract][Full Text] [Related]
16. DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network.
Hamdan FH; Johnsen SA
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12343-E12352. PubMed ID: 30541891
[TBL] [Abstract][Full Text] [Related]
17. CENPE promotes lung adenocarcinoma proliferation and is directly regulated by FOXM1.
Shan L; Zhao M; Lu Y; Ning H; Yang S; Song Y; Chai W; Shi X
Int J Oncol; 2019 Jul; 55(1):257-266. PubMed ID: 31115500
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer.
Pérez-Peña J; Győrffy B; Amir E; Pandiella A; Ocaña A
Breast Cancer Res Treat; 2018 Dec; 172(3):725-732. PubMed ID: 30206781
[TBL] [Abstract][Full Text] [Related]
19. Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration.
Zhou H; Bian T; Qian L; Zhao C; Zhang W; Zheng M; Zhou H; Liu L; Sun H; Li X; Zhang J; Liu Y
Pathol Res Pract; 2021 Dec; 228():153680. PubMed ID: 34798483
[TBL] [Abstract][Full Text] [Related]
20. Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression.
Selamat SA; Chung BS; Girard L; Zhang W; Zhang Y; Campan M; Siegmund KD; Koss MN; Hagen JA; Lam WL; Lam S; Gazdar AF; Laird-Offringa IA
Genome Res; 2012 Jul; 22(7):1197-211. PubMed ID: 22613842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
